Volume 72, Issue 6 (September 2014)
Tehran Univ Med J 2014, 72(6): 412-416 |
Back to browse issues page
1- Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. , Jaffary@pharm.mui.ac.ir
2- Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran. Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
3- Isfahan University of Medical Sciences, Isfahan, Iran.
4- Food Security Research Center, Department of Community nutri-tion, School of Nutrition & Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
2- Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran. Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
3- Isfahan University of Medical Sciences, Isfahan, Iran.
4- Food Security Research Center, Department of Community nutri-tion, School of Nutrition & Food Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. Skin and Leishmania Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract: (5042 Views)
Background: Insulin resistant is important risk factors of diabetes and leads to development of chronic diseases such as diabetes and cardiovascular disease. Recent studies showed association between androgenic alopecia and insulin resistant. However, findings are controversial. Alopecia in women is a common heritable hair loss in central part of head. Aim of this study was investigation of androgenic alopecia distribution in type II diabetes and healthy women and hypothesis testing of relationship between diabetes and androgenic alopecia.
Methods: This is a case-control study. Case and control groups were selected from type II diabetes and healthy women respectively that were refered to clinics of Alzahra, Noor and Amin Hospitals in Isfahan City, Iran in 2011. Participants were selected based on random sampling. Sample size was estimated 141 subjects in each group. Participants were visited by doctor and severity of androgenic alopecia was determined based on Ludwish criteria. Data were analyzed with SPSS software and 2 test. P<0.05 was considered as significant.
Results: Mean age and body mass index were 58.96±12.8 year and 25.6±4.15 kg/m2 respectively in whole population. Findings not show any significant association between type II diabetes and androgenic alopecia (P<0.05). Comparison of distribution of alopecia severity according to Ludwish criteria separately showed similar result. In addition to, there was not any significant relationship between diabetes and alopecia after adjusting with body mass index as confounding factor (P<0.05).
Conclusion: In the present study, there was not any significant relationship between type II diabetes and androgenic alopecia among diabetes and healthy women. However, more researches need to investigate this relationship in both gender and assess insulin resistant indices as homeostasis model assessment-estimated insulin resistance and androgenic alopecia.
Type of Study: Brief Report |
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |